Clinical TrialsSearch results
Number of results: 416
Other
- Phase III Comparative Clinical Trial of Treatment Schedules for Oral UFT/LV Therapy as Postoperative Adjuvant Chemotherapy for Stage IIB/III Colorectal Cancer
- colorectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-09-22
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07
Other
- Phase IIa study (doctor-led trial) for the efficacy and safety of SJP-0008 in central retinal artery occlusion
- central retinal artery occlusion
- Nakazawa Toru
- 2019-12-11
Other
- Phase II trial of neoadjuvant chemotherapy with Bevacizumab plus FOLFOX6 chemotherapy for Resectable case of liver metastasis
- synchronous metastatic liver tumors of colorectal cancer
- Miyagi HBPCOG
- 2008-12-12
Other
- Phase II trial of mFOLFOX6/XELOX plus bevacizumab with oxaliplatin in a stop and go fashion in advanced metastatic colorectal cancer
- advanced colorectal cancer
- Tohoku Clinical oncology, reserach and Education Society (T-CORE)
- 2009-06-05
Other
- Phase II trial of combination chemotherapy consisting of S-1 and Oxaliplatin in patients with advanced or recurrent mucinous adenocarcinoma of the ovary
- Mucinous adenocarcinoma of the ovary including metastatic ovarian cancer
- Japan ovarian mucinous adenocarcinoma study group
- 2009-01-01
Other
- Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)
- unresectable locally advanced squamous cell carcinoma of the head and neck
- Japan Clinical Oncology Group (JCOG)
- 2008-07-28
Other
- Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on KRAS mutation status (T-CORE0801)
- 3rd line or later therapy for unresectable advanced and/or recurrent colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2009-01-31
Other
- Phase II trial neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma patients
- cholangiocarecinoma:Stage III and IV of the Japanese General Rules for Surgical and Pathological Studies on Cancer of the Biliary Tract
- Hepato-biliary pancreatic surgery,Tohoku University Hospital
- 2009-03-04
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01